Westport Resources Management’s Teva Pharmaceuticals TEVA Stock Holding History

Westport Resources Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$207K	Sell	4,500 -935	-17%	-$48.8K	0.15%	141
2016 Q2	$273K	Sell	5,435 -500	-8%	-$26.6K	0.09%	205
2016 Q1	$318K	Hold	5,935	–	–	0.1%	181
2015 Q4	$390K	Hold	5,935	–	–	0.12%	178
2015 Q3	$335K	Hold	5,935	–	–	0.1%	195
2015 Q2	$351K	Sell	5,935 -1,500	-20%	-$92.5K	0.1%	211
2015 Q1	$463K	Sell	7,435 -165	-2%	-$9.59K	0.13%	186
2014 Q4	$437K	Buy	7,600 +200	+3%	+$11.1K	0.12%	201
2014 Q3	$398K	Hold	7,400	–	–	0.11%	215
2014 Q2	$388K	Sell	7,400 -2,200	-23%	-$112K	0.11%	215
2014 Q1	$507K	Buy	9,600 +5,200	+118%	+$240K	0.14%	189
2013 Q4	$176K	Sell	4,400 -550	-11%	-$21.7K	0.05%	306
2013 Q3	$187K	Buy	4,950 +2,000	+68%	+$78K	0.06%	271
2013 Q2	$116K	Buy	+2,950	New	+$115K	0.04%	328

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Westport Resources Management's TEVA Position: Q3 2016 in Review

Westport Resources Management reduced its Teva Pharmaceuticals (TEVA) stake by 17% in Q3 2016, selling an estimated $48.8K and leaving 4,500 shares worth $207K. The position accounts for 0.15% of the portfolio, ranked #141.

Westport Resources Management first reported a position in TEVA in Q2 2013 and has held it in 14 quarters since. The position peaked at $507K in Q1 2014. 795 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

Westport Resources Management held 4,500 shares of Teva Pharmaceuticals worth $207K as of Q3 2016.
Westport Resources Management sold 935 Teva Pharmaceuticals shares in Q3 2016, an estimated $48.8K.
Teva Pharmaceuticals made up 0.15% of Westport Resources Management's portfolio in Q3 2016, its #141 holding.
Westport Resources Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
Westport Resources Management's Teva Pharmaceuticals position peaked at $507K in Q1 2014.
795 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Westport Resources Management's 13F filing for Q3 2016, filed 14 Nov 2016.